BRIEF published on 09/24/2024 at 23:05, 1 year 7 months ago Theralase clôture un placement privé sans intermédiaire et émet des options sur actions Placement Privé Sans Intermédiaire Technologies Théralase Options Sur Actions Financement De La Recherche Clinique Étude Sur Le Cancer De La Vessie
BRIEF published on 09/24/2024 at 23:05, 1 year 7 months ago Theralase Closes Non-Brokered Private Placement and Issues Stock Options Stock Options Non-brokered Private Placement Theralase Technologies Clinical Research Funding Bladder Cancer Study
PRESS RELEASE published on 09/24/2024 at 23:00, 1 year 7 months ago Theralase(R) Closes Non-Brokered Private Placement and Issues Stock Options Theralase Technologies Inc. successfully closes Non-Brokered Private Placement offering of units for cancer research and development Private Placement Pharmaceutical Company Theralase Technologies Inc. Clinical Study Cancer Research
BRIEF published on 09/19/2024 at 23:10, 1 year 7 months ago Theralase® prolonge ses mandats Extension Bourse De Croissance TSX Technologies Théralase Bons De Souscription D'actions Développement Pharmaceutique
BRIEF published on 09/19/2024 at 23:10, 1 year 7 months ago Theralase® Extends Warrants Share Purchase Warrants TSXV Extension Theralase Technologies Pharmaceutical Development
PRESS RELEASE published on 09/19/2024 at 23:05, 1 year 7 months ago Theralase(R) Extends Warrants Theralase Technologies Inc. plans to extend expiry date of 10,000,000 share purchase warrants from Sept 22, 2024, to Sept 22, 2027. Warrants issued in 2022 at $0.35/share. TSXV approval pending TSX Venture Exchange Expiry Date Extension Theralase Technologies Inc. Share Purchase Warrants Clinical Stage Pharmaceutical Company
BRIEF published on 09/03/2024 at 13:05, 1 year 8 months ago Ruvidar(TM) Proven More Effective Than Acyclovir in Destruction of Herpes Simplex Virus Theralase Ruvidar Antiviral Drug HSV-1 Acyclovir
BRIEF published on 09/03/2024 at 13:05, 1 year 8 months ago Ruvidar(TM) s'avère plus efficace que l'acyclovir dans la destruction du virus de l'herpès simplex Theralase Ruvidar Médicament Antiviral HSV-1 Acyclovir
PRESS RELEASE published on 09/03/2024 at 13:00, 1 year 8 months ago Ruvidar(TM) Proven More Effective Than Acyclovir in Destruction of Herpes Simplex Virus Theralase Technologies Inc. announces preclinical superiority of Ruvidar TM in destroying HSV-1 virus, seeking partnerships for commercial development Theralase Technologies Inc. Preclinical Study Partnerships Ruvidar TM HSV-1 Virus
BRIEF published on 08/28/2024 at 13:05, 1 year 8 months ago Rutherrin® augmente l'efficacité de la chimiothérapie contre le cancer du poumon Theralase® Technologies Inc. Chimiothérapie CPNPC Rutherrine® Cisplatine
Published on 05/14/2026 at 14:00, 27 minutes ago Adcore Reports First Quarter 2026 Results: Revenue Up 22% to CAD $8.5 Million, as APAC Grows 42% to CAD $5.5 Million
Published on 05/14/2026 at 14:00, 27 minutes ago Alaska Energy Metals Provides Update On The Nikolai Nickel Project, Alaska / Permitting - Metallurgy - Government Collaboration
Published on 05/14/2026 at 13:30, 57 minutes ago Alset AI Announces First Quarterly Renewal of Lyken.AI Cloud Compute Services Contract with Multinational Technology and Telecommunications Company
Published on 05/14/2026 at 13:30, 57 minutes ago Revival Gold Advances Mercur Project With A View To Be Utah's Next New Operating Gold Mine
Published on 05/14/2026 at 13:30, 57 minutes ago Nepra Foods Enters LOI with KUUK Water to Support Sustainable Beverage Expansion, Hospitality Distribution and E-Commerce Operations
Published on 05/14/2026 at 14:06, 21 minutes ago Billion-Dollar AI deal, $100m in Acquisitions, $25m Founder Buy-In – Diginex Details Expansion Push
Published on 05/14/2026 at 14:05, 22 minutes ago Rockwell Automation Expands EtherNet/IP In-cabinet Solution with New Motor Control and Power Connection Capabilities
Published on 05/14/2026 at 13:40, 47 minutes ago VARON Supports Asthma Awareness Month by Promoting Better Lung Health and Everyday Breathing Comfort
Published on 05/14/2026 at 13:35, 52 minutes ago DeFi Technologies Appoints Russell Starr as Strategic Advisor
Published on 05/14/2026 at 13:30, 57 minutes ago PolyU International Future Challenge 2026 launched to drive innovative ventures through cross-border network of Mainland Translational Research Institutes
Published on 05/14/2026 at 09:03, 5 hours 24 minutes ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 20 hours 25 minutes ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 20 hours 27 minutes ago ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
